Levetiracetam
Product Images NDC 50090-3264

8 FDA label images from A-s Medication Solutions · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 50090-3264). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Label Image (Lbl500903264)

Label Image (Lbl500903264)
Levetiracetam tablet label from A-S Medication Solutions. The label shows the proprietary name Levetiracetam, package quantity of 30 tablets, and storage instructions to keep at 77 degrees Fahrenheit. It also includes the lot number, NDC 50090-3264-0, manufacturer details, and a barcode.*
FDA Label Image

Figure (Levetiracetam Figure 1)

Figure (Levetiracetam Figure 1)
A vertical bar chart comparing the percentage of patients for three groups: Placebo (7.4% with 95 participants), Levetiracetam 1000 mg/day (37.1% with 97 participants), and Levetiracetam 3000 mg/day (39.6% with 101 participants). Each bar includes an asterisk indicating statistical notation.*
FDA Label Image

Figure (Levetiracetam Figure 2)

Figure (Levetiracetam Figure 2)
A bar chart comparing the percentage of patients across three groups: Placebo (N=111) at 6.3%, Levetiracetam 1000 mg/day (N=106) at 20.8%, and Levetiracetam 2000 mg/day (N=105) at 35.2%. The Y-axis represents the percentage of patients.*
FDA Label Image

Figure (Levetiracetam Figure 3)

Figure (Levetiracetam Figure 3)
Bar chart comparing the percentage of patients between two groups: Placebo (N=104) and Levetiracetam 3000 mg/day (N=180). The chart shows approximately 14.4% of patients in the placebo group and 39.4% in the Levetiracetam group, with an asterisk indicating statistical significance for the Levetiracetam group.*
FDA Label Image

Figure (Levetiracetam Figure 4)

Figure (Levetiracetam Figure 4)
A bar graph comparing the percentage of patients receiving Placebo (N=97) versus Levetiracetam (N=101). The graph shows approximately 19.6% for the Placebo group and 44.6% for the Levetiracetam group on the Y-axis labeled % of Patients.*
FDA Label Image

Figure (Levetiracetam Figure 5)

Figure (Levetiracetam Figure 5)
A bar graph comparing the percentage of patients for placebo and Levetiracetam groups. The y-axis shows the percentage of patients from 0% to 45%. The placebo group has a bar at 19.6% (N=51), while the Levetiracetam group shows a higher bar at 43.1% (N=58).*
FDA Label Image

Figure (Levetiracetam Figure 6)

Figure (Levetiracetam Figure 6)
A vertical bar chart comparing the percentage of patients between two groups: Placebo and Levetiracetam. The Placebo group (N=84) shows 45.2% of patients, while the Levetiracetam group (N=79) shows 72.2% of patients. The y-axis is labeled as '% of Patients', ranging from 0% to 100%.*
FDA Label Image

Chemical Structure (Levetiracetam Structure)

Chemical Structure (Levetiracetam Structure)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.